Abalos Therapeutics completes Series A extension bringing total raised to EUR43m
Abalos Therapeutics has completed its Series A funding round bringing the total raised in this round to EUR43 million (USD50 million). The extension was led by Seventure Partners with support from Coparion, Ventura BioMed Investors and Hx Bio Ventures as well as contributions from existing investors from the initial Series
